Xianan Guo

3PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 16, 2023
First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis.

Xianan Guo, Yunxiang Zhou, Kun Zhang

|Jul 05, 2022
Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition.

Xianan Guo, Huihui Chen, Yunxiang Zhou

Pageof 1